A University of California at Berkeley academic is proposing a series of major reforms to the 340B discount drug program [...] …
Articles by : Rich Daly, Editor in Chief
Long-awaited federal legislation to bar drugmaker restrictions on 340B contract pharmacy arrangements was introduced today. The Mar 12 bill sponsored [...] …
Drugmaker Genentech has given some 340B hospitals advance notice of its plan to implement contract pharmacy restrictions. The biotech giant, [...] …
Despite the looming finalization of a major policy change, this week’s fiscal year 2025 budget request would freeze the budget [...] …
A national hospital advocacy group “insists” multiple television stations remove a dark money group’s political ads alleging federal funding for [...] …
Massachusetts will soon change its Medicaid payment policy to bar managed care plans from paying for seven high-cost, anti-obesity medications [...] …
Drugmaker Genentech announced multi-year refunds to 340B providers on past purchases of two separate high-selling drugs, while Merck offered a [...] …
The Centers for Medicare & Medicaid Services (CMS) will direct Medicare administrative contractors (MACs) to provide some accelerated payments to [...] …
Building America’s Future, a nonprofit advocacy group that previously focused on trade, infrastructure, and tobacco issues, recently pushed into drug [...] …
Drugmaker Liquidia will implement contract pharmacy restrictions for a single drug that has a still-pending new drug application (NDA). The [...] …